Kelyniam Global, Inc.

KLYGOTCHealthcare● Active

$0.14

+$0.00(+0.00%)

Market Cap$1764000

P/E Ratio—

52W High$0.3

52W Low$0.05

Avg Volume23K

Open$0.14

Beta-0.06

Free Cash Flow Financials Revenue

Kelyniam Global, Inc. (KLYG) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

KLYG · free cash flow · updated Jun 15, 2026

Core FCF metrics

KLYG · FCF · TTM · margin & CAGR

Free cash flow was −$193,860 for FY2025 (fiscal year ending 2025-12-31), down 299.8% year-over-year The FCF margin was -6.3%.

FY2025 Free Cash Flow−$193,860▼ -299.8% YoY

Trailing 12M (TTM)$83,380Trailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-6.3%−$193,860 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

KLYG · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$193,858(0M)−$193,860▼ 299.8%-6.3%

FY2024$103,581(0M)$97,020▲ +201.3%2.9%

FY2023−$95,773(0M)−$95,770▼ 14.8%-3.6%

FY2022−$31,753(0M)−$83,457▼ 173.4%-2.8%

FY2021$124,297(0M)$113,661▼ 25.9%4.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

KLYG · P/FCF · FCF yield · FCF per share

Kelyniam Global, Inc. (KLYG) trades at a FCF yield of 4.73% and a price-to-free-cash-flow ratio of N/A. FCF per share stands at $0.00, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

4.73%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.00

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

x23.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

KLYG · cash flow statement · operating / investing / financing

For FY2025, Kelyniam Global, Inc. generated −$0.2M in operating cash flow and spent 0M in capital expenditures, yielding −$0.2M in free cash flow.

Operating Activities

−$0.2M

Cash from core business operations

2025-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$0.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$0.2M) − |CapEx| (0M) = FCF (−$0.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

KLYG vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Kelyniam Global, Inc.YOU

KLYG

−$193,860-299.8%-6.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Kelyniam Global, Inc. (KLYG) reported free cash flow of −$193,860 for FY2025 (fiscal year ending 2025-12-31), down 299.8% year-over-year. The FCF margin was -6.3%.

Based on available data, Kelyniam Global, Inc. has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $153,438 in FY2020.

Kelyniam Global, Inc.'s FCF yield is 4.73% and price-to-FCF ratio is N/A for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

KLYG free cash flow · 8 questions

Kelyniam Global, Inc. free cash flow was −$193,860 for FY2025, down 299.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $83,380.

KLYG free cash flowKLYG FCFKLYG FCF 2025KLYG free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Kelyniam Global, Inc. · Kelyniam Global, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026